查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762257

神经刺激设备市场、规模、占有率、趋势、产业分析报告：依应用、设备、地区、市场预测2025-2034

Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application, Devices, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，全球神经刺激设备市场预计到2034年将达到 236.3亿美元。本研究报告对当前市场动态提供了详细的见解，并对未来的市场成长进行了分析。

神经刺激设备市场包括向神经系统传递电脉衝以调节神经活动的医疗设备，主要用于治疗慢性疼痛、癫痫、帕金森氏症、特发性震颤和其他神经系统疾病。

由于神经系统疾病盛行率上升、对微创治疗方案的需求增加以及人工智慧整合和无线刺激等技术进步，市场经历显着成长。神经刺激设备的市场机会在于这些设备在新兴市场的日益普及，以及其用途超越认知障碍和肥胖管理等传统适应症的扩展。

主要趋势包括可充电和小型化设备的发展、行业参与者之间的策略联盟以及推动神经刺激设备市场扩张的监管部门的批准。随着医疗保健基础设施的改善和意识的提高，在技术创新和不断变化的患者需求的推动下，市场稳步成长。

神经刺激设备市场报告重点

根据应用，由于慢性疼痛症盛行率上升和脊髓刺激器的采用率增加，疼痛管理领域占据了最大的市场占有率。

依装置类型，深部脑部刺激设备是成长最快的类别，这得益于其在帕金森氏症和特发性震颤等运动障碍方面的应用不断扩大。

由于高昂的医疗保健支出、强有力的监管批准以及神经刺激设备的广泛采用，北美在市场中处于领先地位。

随着医疗保健基础设施的改善、意识的增强以及神经系统疾病盛行率的上升，亚太地区经历显着的成长。

神经刺激设备市场有几个关键参与者积极为医疗技术的进步做出贡献。主要公司包括Abbott Laboratories、Aleva Neurotherapeutics、Boston Scientific Corporation、Cognito Therapeutics、ElectroCore, Inc、LivaNova PLC、Medtronic plc、Nalu Medical, Inc、Neuronetics, Inc、NeuroPace, Inc、Nevro Corp、Synapse Biomedical Inc。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球神经刺激设备市场洞察

  • 市场概况
  • 神经刺激设备市场动态
    • 驱动因素和机会
      • 神经系统疾病盛行率不断上升
      • 神经刺激技术的进步
    • 抑制因素和挑战
      • 设备和程式成本高昂
  • PESTEL 分析
  • 神经刺激设备的市场趋势
  • 价值链分析
  • COVID-19 影响分析

第5章 全球神经刺激设备市场（依应用）

  • 主要调查结果
  • 简介
  • 疼痛管理
  • 癫痫
  • 特发性震颤
  • 尿失禁及大便失禁
  • 忧郁症

第6章 全球神经刺激设备市场（依设备）

  • 主要调查结果
  • 简介
  • 脊髓刺激装置
  • 深部脑部刺激装置
  • 荐神经刺激装置
  • 迷走神经刺激装置
  • 胃电刺激装置

第7章 全球神经刺激设备市场（依地区）

  • 主要调查结果
  • 简介
    • 神经刺激设备市场分析：地区，2020-2034
  • 北美
    • 北美：依应用，2020-2034年
    • 北美：依设备，2020-2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲，依应用，2020-2034年
    • 欧洲：依设备，2020-2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 亚太地区：依应用，2020-2034年
    • 亚太地区：依设备，2020-2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东和非洲
    • 中东和非洲：依应用，2020-2034年
    • 中东和非洲：依设备，2020-2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 拉丁美洲：依应用，2020-2034年
    • 拉丁美洲：依设备，2020-2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第8章 竞争格局

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/公开

第9章 公司简介

  • Abbott Laboratories
  • Advanced Bionics（a Sonova Group company）
  • Aleva Neurotherapeutics
  • Boston Scientific Corporation
  • Cochlear Limited
  • Cognito Therapeutics
  • ElectroCore, Inc.
  • Inspire Medical Systems, Inc.
  • LivaNova PLC
  • Medtronic plc
Product Code: PM3256

The global neurostimulation devices market size is expected to reach USD 23.63 billion by 2034, according to a new study by Polaris Market Research. The report "Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application (Pain Management, Epilepsy, Essential Tremor, Urinary & Faecal Incontinence, and Depression), Devices, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neurostimulation devices market consists of medical devices that deliver electrical impulses to the nervous system to modulate neural activity, primarily used for managing chronic pain, epilepsy, Parkinson's disease, essential tremor, and other neurological conditions.

The market is experiencing significant growth due to the rising prevalence of neurological disorders, increasing demand for minimally invasive treatment options, and advancements in technology, including AI integration and wireless stimulation. Neurostimulation devices market opportunities lie in expanding applications beyond traditional indications, such as in cognitive disorders and obesity management, along with the growing adoption of these devices in emerging markets.

Key trends include the development of rechargeable and miniaturized devices, strategic collaborations among industry players, and regulatory approvals facilitating neurostimulation devices market expansion. As healthcare infrastructure improves and awareness increases, the market continues to witness steady growth, driven by innovation and evolving patient needs.

Neurostimulation Devices Market Report Highlights

By application, the pain management segment holds the largest market share due to the rising prevalence of chronic pain conditions and the increasing adoption of spinal cord stimulators.

By devices, the deep brain stimulators segment is experiencing the fastest growth, supported by their expanding use in movement disorders such as Parkinson's disease and essential tremor.

North America leads the market due to high healthcare spending, strong regulatory approvals, and widespread adoption of neurostimulation devices.

Asia Pacific is experiencing significant growth, driven by improving healthcare infrastructure, rising awareness, and increasing prevalence of neurological disorders.

The neurostimulation devices market features several key players actively contributing to advancements in medical technology. Prominent companies include Abbott Laboratories; Aleva Neurotherapeutics; Boston Scientific Corporation; Cognito Therapeutics; ElectroCore, Inc.; LivaNova PLC; Medtronic plc; Nalu Medical, Inc.; Neuronetics, Inc.; NeuroPace, Inc.; Nevro Corp.; and Synapse Biomedical Inc.

Polaris Market Research has segmented the neurostimulation devices market report on the basis of application, devices, and region:

By Application Outlook (Revenue - USD Billion, 2020-2034)

Pain Management

Epilepsy

Essential Tremor

Urinary & Faecal Incontinence

Depression

By Devices Outlook (Revenue - USD Billion, 2020-2034)

Spinal Cord Stimulator

Deep Brain Stimulator

Sacral Nerve Stimulator

Vagus Nerve Stimulator

Gastric Electric Stimulator

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Neurostimulation Devices Market Insights

  • 4.1. Neurostimulation Devices Market - Market Snapshot
  • 4.2. Neurostimulation Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Neurological Disorders
      • 4.2.1.2. Advancements in Neurostimulation Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Devices and Procedures
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Neurostimulation Devices Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Neurostimulation Devices Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • 5.3. Pain Management
    • 5.3.1. Global Neurostimulation Devices Market, by Pain Management, by Region, 2020-2034 (USD Billion)
  • 5.4. Epilepsy
    • 5.4.1. Global Neurostimulation Devices Market, by Epilepsy, by Region, 2020-2034 (USD Billion)
  • 5.5. Essential Tremor
    • 5.5.1. Global Neurostimulation Devices Market, by Essential Tremor, by Region, 2020-2034 (USD Billion)
  • 5.6. Urinary & Faecal Incontinence
    • 5.6.1. Global Neurostimulation Devices Market, by Urinary & Faecal Incontinence, by Region, 2020-2034 (USD Billion)
  • 5.7. Depression
    • 5.7.1. Global Neurostimulation Devices Market, by Depression, by Region, 2020-2034 (USD Billion)

6. Global Neurostimulation Devices Market, by Devices

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 6.3. Spinal Cord Stimulator
    • 6.3.1. Global Neurostimulation Devices Market, by Spinal Cord Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.4. Deep Brain Stimulator
    • 6.4.1. Global Neurostimulation Devices Market, by Deep Brain Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.5. Sacral Nerve Stimulator
    • 6.5.1. Global Neurostimulation Devices Market, by Sacral Nerve Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.6. Vagus Nerve Stimulator
    • 6.6.1. Global Neurostimulation Devices Market, by Vagus Nerve Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.7. Gastric Electric Stimulator
    • 6.7.1. Global Neurostimulation Devices Market, by Gastric Electric Stimulator, by Region, 2020-2034 (USD Billion)

7. Global Neurostimulation Devices Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Neurostimulation Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Neurostimulation Devices Market - North America
    • 7.3.1. North America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.3.2. North America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.3.3. Neurostimulation Devices Market - U.S.
      • 7.3.3.1. U.S.: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.3.4. Neurostimulation Devices Market - Canada
      • 7.3.4.1. Canada: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4. Neurostimulation Devices Market - Europe
    • 7.4.1. Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.3. Neurostimulation Devices Market - UK
      • 7.4.3.1. UK: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.4. Neurostimulation Devices Market - France
      • 7.4.4.1. France: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.5. Neurostimulation Devices Market - Germany
      • 7.4.5.1. Germany: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.6. Neurostimulation Devices Market - Italy
      • 7.4.6.1. Italy: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.7. Neurostimulation Devices Market - Spain
      • 7.4.7.1. Spain: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.8. Neurostimulation Devices Market - Netherlands
      • 7.4.8.1. Netherlands: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.9. Neurostimulation Devices Market - Russia
      • 7.4.9.1. Russia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.10. Neurostimulation Devices Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5. Neurostimulation Devices Market - Asia Pacific
    • 7.5.1. Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.3. Neurostimulation Devices Market - China
      • 7.5.3.1. China: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.4. Neurostimulation Devices Market - India
      • 7.5.4.1. India: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.5. Neurostimulation Devices Market - Malaysia
      • 7.5.5.1. Malaysia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.6. Neurostimulation Devices Market - Japan
      • 7.5.6.1. Japan: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.7. Neurostimulation Devices Market - Indonesia
      • 7.5.7.1. Indonesia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.8. Neurostimulation Devices Market - South Korea
      • 7.5.8.1. South Korea: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.9. Neurostimulation Devices Market - Australia
      • 7.5.9.1. Australia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.10. Neurostimulation Devices Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.6. Neurostimulation Devices Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.3. Neurostimulation Devices Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.4. Neurostimulation Devices Market - UAE
      • 7.6.4.1. UAE: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.5. Neurostimulation Devices Market - Israel
      • 7.6.5.1. Israel: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.6. Neurostimulation Devices Market - South Africa
      • 7.6.6.1. South Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.7. Neurostimulation Devices Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.7. Neurostimulation Devices Market - Latin America
    • 7.7.1. Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.3. Neurostimulation Devices Market - Mexico
      • 7.7.3.1. Mexico: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.4. Neurostimulation Devices Market - Brazil
      • 7.7.4.1. Brazil: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.5. Neurostimulation Devices Market - Argentina
      • 7.7.5.1. Argentina: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.6. Neurostimulation Devices Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Advanced Bionics (a Sonova Group company)
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Aleva Neurotherapeutics
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Boston Scientific Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Cochlear Limited
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Cognito Therapeutics
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. ElectroCore, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Inspire Medical Systems, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. LivaNova PLC
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Medtronic plc
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

  • Table 1 Global Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 2 Global Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 3 North America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 4 North America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 5 U.S.: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 6 U.S.: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 7 Canada: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 8 Canada: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 9 Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 10 Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 11 UK: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 12 UK: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 13 France: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 14 France: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 15 Germany: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Germany: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 17 Italy: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 18 Italy: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 19 Spain: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Spain: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 23 Russia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Russia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 29 China: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 30 China: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 31 India: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 32 India: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 35 Japan: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Japan: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 39 South Korea: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 40 South Korea: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 41 Australia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Australia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 49 UAE: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 50 UAE: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 51 Israel: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Israel: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 53 South Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 54 South Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 57 Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 58 Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 59 Mexico: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 60 Mexico: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 61 Brazil: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 62 Brazil: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 63 Argentina: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 64 Argentina: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Neurostimulation Devices Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Neurostimulation Devices Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Devices
  • Figure 9. Global Neurostimulation Devices Market, by Devices, 2024 & 2034 (USD Billion)